Company

Company History

Next generation cell & gene therapeutics development company

AffyXell Therapeutics

HISTORY
2022
  • May

    Selected for a government project of the Ministry of Trade, Industry and Energy

  • April

    Selected as a target of two by the Korean Fund for Regenerative Medicine(KFRM) (3.6 billion won)

2021
  • July

    Opened AffyXell Innovation Cube (AIC), Gimhae

  • February

    Approved as research institute by KOITA (Korea Industrial Technology Association)

  • January

    $7.3 Million series A Financing

2020
  • December

    Approval of LMO facility, AFX platform R&D Center (Gwanggyo)
    Selected of government R&D project by Ministry of Science and ICT.

  • November

    1st vial cracking ceremony

  • October

    Founded AFX platform R&D center

  • September

    Headquarters relocated to Gimhae

  • March

    Daewoong AffyXell TF launched

  • February

    Registered a business

  • January

    Incorporated ‘AffyXell Therapeutics Co. Ltd.,’